B&K Corporation Ltd

Recent Articles

RELATED ARTICLES

  1. The drugs giant has licensed an experimental anti-obesity pill from China’s Eccogene as it tries to grab a chunk of the lucrative weight-loss market.
    AstraZeneca pays hefty price for Chinese weight-loss drug
    AZN.US
  2. Kintor shares plunge after hair-loss drug flops in clinical trials
    9939.HK
  3. InSilico seeks IPO boost to get AI drugs over the line
  4. HighTide Therapeutics places big IPO bet on “affluenza” drug
  5. Akeso marks profit milestone with swift rights issue
    9926.HK
  6. With no cure in sight, drugs firm LianBio begins exit strategy
    LIAN.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva